These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 162334

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Functional analysis of immune complex-rich serum fractions in autoimmune diseases by in vitro C3 activation of fresh blood].
    Böhm U, Merétey K, Falus A, Bozsóky S.
    Z Rheumatol; 1981; 40(3):126-30. PubMed ID: 6456623
    [Abstract] [Full Text] [Related]

  • 24. Studies of circulating immune complexes in ankylosing spondylitis.
    Kinsella TD, Lanteigne C, Lewkonia RM, Fritzler MJ.
    Clin Invest Med; 1982; 5(4):223-30. PubMed ID: 7160109
    [Abstract] [Full Text] [Related]

  • 25. Autoantibodies to tumor necrosis factor in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Rosenau BJ, Schur PH.
    J Rheumatol; 2009 Apr; 36(4):753-6. PubMed ID: 19273453
    [Abstract] [Full Text] [Related]

  • 26. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
    Chia D, Barnett EV, Yamagata J, Knutson D, Restivo C, Furst D.
    Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
    [Abstract] [Full Text] [Related]

  • 27. [The levels of circulating immune complexes and immunoglobulins in patients with systemic lupus erythematosus and rheumatoid arthritis].
    Ternovoĭ KS, Gandzha IM, Babynina LIa, Volobueva ZV, Sukharenko NV, Dibrova TN, Selezneva TN, Ermekova VM.
    Vrach Delo; 1990 Apr; (4):48-50. PubMed ID: 2275166
    [Abstract] [Full Text] [Related]

  • 28. Antihistone antibodies detected by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis.
    Costa O, Monier JC.
    J Rheumatol; 1986 Aug; 13(4):722-5. PubMed ID: 3772919
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F, Siddiqui AA.
    Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
    [Abstract] [Full Text] [Related]

  • 30. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE, Moss IK, Mumford P, Horsfall A, Maini RN.
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [Abstract] [Full Text] [Related]

  • 31. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CH.
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [Abstract] [Full Text] [Related]

  • 32. [Determination of immune complexes in renal diseases (author's transl)].
    Smolen JS, Wolf A, Scherak O, Syre G, Pinggera W, Stummvoll HK, Leithner C, Menzel EJ.
    Acta Med Austriaca; 1981 Dec; 8(2):37-41. PubMed ID: 6456639
    [Abstract] [Full Text] [Related]

  • 33. Antibodies to ribonucleic acids detected by ELISA in systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis.
    Costa O, Pinatel K, Monier JC.
    J Rheumatol; 1985 Oct; 12(5):928-33. PubMed ID: 2418204
    [Abstract] [Full Text] [Related]

  • 34. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA.
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [Abstract] [Full Text] [Related]

  • 35. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ.
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [Abstract] [Full Text] [Related]

  • 36. [Catalytic autoantibodies as a new molecular instrument in rheumatological practice].
    Khitrov AN, Mal'tsev KA, Vvedenskaia OIu, Ponomarenko NA, Isaeva MA, Kimova MV, Tret'iak EB, Shogenov ZS, Alekberova ZS, Gabibov AG, Suchkov SV.
    Ter Arkh; 2006 Sep; 78(6):59-66. PubMed ID: 16881365
    [Abstract] [Full Text] [Related]

  • 37. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA, Herrmann D, Vogt KH, Jäger L.
    Allerg Immunol (Leipz); 1991 Sep; 37(1):37-45. PubMed ID: 2063729
    [Abstract] [Full Text] [Related]

  • 38. Circulating autoantibodies to IgD in rheumatic diseases.
    Pope RM, Keightley R, McDuffy S.
    J Immunol; 1982 Apr; 128(4):1860-3. PubMed ID: 6977573
    [Abstract] [Full Text] [Related]

  • 39. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
    Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M.
    Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
    [Abstract] [Full Text] [Related]

  • 40. Circulating immune complexes in IgA deficiency.
    Kwitko AO, McKenzie PE, Shearman DJ, Gormly AA, Woodroffe AJ.
    Clin Exp Immunol; 1979 Oct; 38(1):45-51. PubMed ID: 527254
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.